Back
Relmada Therapeutics Quote, Financials, Valuation and Earnings
America's Final Republican President
Click here to see his 2024 election prediction.
Sell
40
RLMD
Relmada Therapeutics
Last Price:
3.69
Seasonality Move:
-13.22%
7 Day Trial
ALL ACCESS PASS
$
7
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!Relmada Therapeutics Price Quote
$3.69
Relmada Therapeutics Key Stats
Sell
40
Relmada Therapeutics (RLMD)
is a Sell
Day range:
$3.62 - $3.83
52-week range:
$2.36 - $7.22
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.3%
Volume:
64K
Avg. volume:
168.3K
1-year change:
35.66%
Market cap:
$111.3M
Revenue:
$0
EPS:
$-3.27
How Much Does Relmada Therapeutics Make?
Data Unavailable
Is Relmada Therapeutics Growing As A Company?
Data Unavailable
Relmada Therapeutics Stock Price Performance
-
Did Relmada Therapeutics Stock Go Up Last Month?
Relmada Therapeutics share price went down by -24.39% last month -
Did RLMD's Share Price Rise Over The Last Year?
RLMD share price rose by 35.66% over the past 1 year
What Is Relmada Therapeutics 52-Week High & Low?
-
What Is Relmada Therapeutics’s 52-Week High Share Price?
Relmada Therapeutics has traded as high as $7.22 over the past 52 weeks -
What Is Relmada Therapeutics’s 52-Week Low Share Price?
Relmada Therapeutics has traded as low as $2.36 over the past 52 weeks
Relmada Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Relmada Therapeutics?
-
How Much Debt Does Relmada Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Relmada Therapeutics Have?
Cash and short term investments quarterly total is $96.3M -
What Is Relmada Therapeutics’s Book Value Per Share?
Book value per share is 2.84
Is Relmada Therapeutics Cash Flow Positive?
-
What Is RLMD Cash Flow From Operations?
Cash flow from operations (TTM) is -$51.7M -
What Is Relmada Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$98.5K -
What Is Relmada Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $50.5M
Relmada Therapeutics Return On Invested Capital
Data Unavailable
Relmada Therapeutics Earnings Date & Stock Price
-
What Is Relmada Therapeutics's Stock Price Today?
A single share of RLMD can be purchased today for 3.69 -
What Is Relmada Therapeutics’s Stock Symbol?
Relmada Therapeutics trades on the nasdaq under the ticker symbol: RLMD -
When Is Relmada Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Relmada Therapeutics is scheduled on May 10, 2024 -
When Is RLMD's next ex-dividend date?
Relmada Therapeutics's next ex-dividend date is May 2, 2024 -
How To Buy Relmada Therapeutics Stock?
You can buy Relmada Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Relmada Therapeutics Competitors
-
Who Are Relmada Therapeutics's Competitors?
Below is a list of companies who compete with Relmada Therapeutics or are related in some way:
Relmada Therapeutics Dividend Yield
Data Unavailable
Relmada Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 10.88 |
| Upside from Last Price: | 194.72% |